What is Targeted Growth?
Founded with the mission to enhance agricultural productivity, Targeted Growth has evolved into a global leader in bioscience. The company specializes in developing innovative technologies aimed at increasing seed size and yield for both commercial food crops and biofuel feedstocks. Through strategic collaborations with leading researchers and agribusinesses worldwide, Targeted Growth is at the forefront of agricultural innovation, addressing critical needs in food security and sustainable energy.
How much funding has Targeted Growth raised?
Targeted Growth has raised a total of $30.6M across 4 funding rounds:
Debt
$22.3M
Unspecified
$2M
Debt
$5M
Unspecified
$1.3M
Debt (2007): $22.3M with participation from AllianceBernstein, Capricorn Investment Group, and Integra Ventures
Unspecified (2012): $2M led by Capricorn Investment Group
Debt (2012): $5M supported by Capricorn Investment Group, Integra Ventures, and AllianceBernstein
Unspecified (2013): $1.3M, investors not publicly disclosed
Key Investors in Targeted Growth
Capricorn Investment Group
Capricorn Investment Group is a Palo Alto-based investment firm focused on sustainable, climate, and impact investments, managing diversified portfolios for aligned families, foundations, and institutional investors. They back companies and funds addressing global environmental and social challenges.
Integra Ventures
Integra Ventures is a leading healthcare consulting firm specializing in strategic, financial, and operational solutions for healthcare providers across India. They focus on enhancing healthcare infrastructure and offer services including hospital management consultancy and public health systems strengthening.
AllianceBernstein
AllianceBernstein Holding L.P. is a publicly owned investment manager providing services to a wide range of clients, including investment companies, pension plans, and individuals. They manage separate client-focused portfolios and invest across various asset classes.
What's next for Targeted Growth?
The substantial enterprise-level capital infusion signifies a pivotal moment for Targeted Growth, positioning it for accelerated expansion and further research and development. This strategic backing is expected to bolster the company's global reach and deepen its technological capabilities in crop science and bioscience. The investment will likely support scaling operations, expanding market penetration, and continuing its commitment to developing advanced agricultural solutions.
See full Targeted Growth company page
